124 related articles for article (PubMed ID: 26542308)
1. Gain of chromosome 21 or amplification of chromosome arm 21q is one mechanism for increased ERG expression in acute myeloid leukemia.
Weber S; Haferlach C; Jeromin S; Nadarajah N; Dicker F; Noël L; Zenger M; Alpermann T; Kern W; Haferlach T; Schnittger S
Genes Chromosomes Cancer; 2016 Feb; 55(2):148-57. PubMed ID: 26542308
[TBL] [Abstract][Full Text] [Related]
2. Acute myeloid leukemia with complex karyotypes and abnormal chromosome 21: Amplification discloses overexpression of APP, ETS2, and ERG genes.
Baldus CD; Liyanarachchi S; Mrózek K; Auer H; Tanner SM; Guimond M; Ruppert AS; Mohamed N; Davuluri RV; Caligiuri MA; Bloomfield CD; de la Chapelle A
Proc Natl Acad Sci U S A; 2004 Mar; 101(11):3915-20. PubMed ID: 15007164
[TBL] [Abstract][Full Text] [Related]
3. High expression levels of the ETS-related gene, ERG, predict adverse outcome and improve molecular risk-based classification of cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B Study.
Marcucci G; Maharry K; Whitman SP; Vukosavljevic T; Paschka P; Langer C; Mrózek K; Baldus CD; Carroll AJ; Powell BL; Kolitz JE; Larson RA; Bloomfield CD;
J Clin Oncol; 2007 Aug; 25(22):3337-43. PubMed ID: 17577018
[TBL] [Abstract][Full Text] [Related]
4. Marker chromosomes are a significant mechanism of high-level RUNX1 gene amplification in hematologic malignancies.
Moosavi SA; Sanchez J; Adeyinka A
Cancer Genet Cytogenet; 2009 Feb; 189(1):24-8. PubMed ID: 19167608
[TBL] [Abstract][Full Text] [Related]
5. Loss of genetic material is more common than gain in acute myeloid leukemia with complex aberrant karyotype: a detailed analysis of 125 cases using conventional chromosome analysis and fluorescence in situ hybridization including 24-color FISH.
Schoch C; Haferlach T; Bursch S; Gerstner D; Schnittger S; Dugas M; Kern W; Löffler H; Hiddemann W
Genes Chromosomes Cancer; 2002 Sep; 35(1):20-9. PubMed ID: 12203786
[TBL] [Abstract][Full Text] [Related]
6. Amplified segment in the 'Down syndrome critical region' on HSA21 shared between Down syndrome and euploid AML-M0 excludes RUNX1, ERG and ETS2.
Canzonetta C; Hoischen A; Giarin E; Basso G; Veltman JA; Nacheva E; Nizetic D; Groet J
Br J Haematol; 2012 Apr; 157(2):197-200. PubMed ID: 22221250
[TBL] [Abstract][Full Text] [Related]
7. Amplification or duplication of chromosome band 21q22 with multiple copies of the AML1 gene and mutation of the TP53 gene in therapy-related MDS and AML.
Andersen MK; Christiansen DH; Pedersen-Bjergaard J
Leukemia; 2005 Feb; 19(2):197-200. PubMed ID: 15618958
[TBL] [Abstract][Full Text] [Related]
8. ERG expression is an independent prognostic factor and allows refined risk stratification in cytogenetically normal acute myeloid leukemia: a comprehensive analysis of ERG, MN1, and BAALC transcript levels using oligonucleotide microarrays.
Metzeler KH; Dufour A; Benthaus T; Hummel M; Sauerland MC; Heinecke A; Berdel WE; Büchner T; Wörmann B; Mansmann U; Braess J; Spiekermann K; Hiddemann W; Buske C; Bohlander SK
J Clin Oncol; 2009 Oct; 27(30):5031-8. PubMed ID: 19752345
[TBL] [Abstract][Full Text] [Related]
9. ELF4 is fused to ERG in a case of acute myeloid leukemia with a t(X;21)(q25-26;q22).
Moore SD; Offor O; Ferry JA; Amrein PC; Morton CC; Dal Cin P
Leuk Res; 2006 Aug; 30(8):1037-42. PubMed ID: 16303180
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of the ETS-related gene, ERG, predicts a worse outcome in acute myeloid leukemia with normal karyotype: a Cancer and Leukemia Group B study.
Marcucci G; Baldus CD; Ruppert AS; Radmacher MD; Mrózek K; Whitman SP; Kolitz JE; Edwards CG; Vardiman JW; Powell BL; Baer MR; Moore JO; Perrotti D; Caligiuri MA; Carroll AJ; Larson RA; de la Chapelle A; Bloomfield CD
J Clin Oncol; 2005 Dec; 23(36):9234-42. PubMed ID: 16275934
[TBL] [Abstract][Full Text] [Related]
11. The human erg gene maps to chromosome 21, band q22: relationship to the 8; 21 translocation of acute myelogenous leukemia.
Rao VN; Modi WS; Drabkin HD; Patterson D; O'Brien SJ; Papas TS; Reddy ES
Oncogene; 1988 Nov; 3(5):497-500. PubMed ID: 3274086
[TBL] [Abstract][Full Text] [Related]
12. Two novel translocations disrupt the RUNX1 gene in acute myeloid leukemia.
Dai H; Xue Y; Pan J; Wu Y; Wang Y; Shen J; Zhang J
Cancer Genet Cytogenet; 2007 Sep; 177(2):120-4. PubMed ID: 17854666
[TBL] [Abstract][Full Text] [Related]
13. RUNX1 amplification in AML with myelodysplasia-related changes and ring 21 chromosomes.
Burillo-Sanz S; Vargas MT; Morales-Camacho RM; Caballero-Velázquez T; Sánchez J; García-Lozano JR; Pérez de Soto I; Prats-Martín C; Bernal R; Pérez-Simón JA
Hematol Oncol; 2017 Dec; 35(4):894-899. PubMed ID: 26947932
[TBL] [Abstract][Full Text] [Related]
14. RUNX1 deletion/amplification in therapy-related acute myeloid leukemia: A case report and review of the literature.
Nguyen D; Li Y; Safah H; Brown TC
Cancer Genet; 2019 Oct; 238():37-43. PubMed ID: 31425924
[TBL] [Abstract][Full Text] [Related]
15. Gains, losses and complex karyotypes in myeloid disorders: a light at the end of the tunnel.
Alvarez S; Cigudosa JC
Hematol Oncol; 2005 Mar; 23(1):18-25. PubMed ID: 16142824
[TBL] [Abstract][Full Text] [Related]
16. Acute myeloid leukemia with del(X)(p21) and cryptic RUNX1/RUNX1T1 from ins(8;21)(q22;q22q22) revealed by atypical FISH signals.
Jang JH; Yoo EH; Kim HJ; Kim DH; Jung CW; Kim SH
Ann Clin Lab Sci; 2010; 40(1):80-4. PubMed ID: 20124335
[TBL] [Abstract][Full Text] [Related]
17. The AML1 gene: a transcription factor involved in the pathogenesis of myeloid and lymphoid leukemias.
Lo Coco F; Pisegna S; Diverio D
Haematologica; 1997; 82(3):364-70. PubMed ID: 9234595
[TBL] [Abstract][Full Text] [Related]
18. AML/MDS with 11q/MLL amplification show characteristic gene expression signature and interplay of DNA copy number changes.
Zatkova A; Merk S; Wendehack M; Bilban M; Muzik EM; Muradyan A; Haferlach C; Haferlach T; Wimmer K; Fonatsch C; Ullmann R
Genes Chromosomes Cancer; 2009 Jun; 48(6):510-20. PubMed ID: 19306356
[TBL] [Abstract][Full Text] [Related]
19. ETV6 rearrangements are recurrent in myeloid malignancies and are frequently associated with other genetic events.
Haferlach C; Bacher U; Schnittger S; Alpermann T; Zenger M; Kern W; Haferlach T
Genes Chromosomes Cancer; 2012 Apr; 51(4):328-37. PubMed ID: 22162288
[TBL] [Abstract][Full Text] [Related]
20. High expression of c-kit mRNA predicts unfavorable outcome in adult patients with t(8;21) acute myeloid leukemia.
Gao X; Lin J; Gao L; Deng A; Lu X; Li Y; Wang L; Yu L
PLoS One; 2015; 10(4):e0124241. PubMed ID: 25860287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
